Corpus ID: 49362400

Lack of Influence of XRCC 1 and XPD Gene Polymorphisms on Outcome of Platinum-based Chemotherapy for Advanced Non Small Cell Lung Cancers

@inproceedings{Yao2010LackOI,
  title={Lack of Influence of XRCC 1 and XPD Gene Polymorphisms on Outcome of Platinum-based Chemotherapy for Advanced Non Small Cell Lung Cancers},
  author={Chengyun Yao and Xin-en Huang and C. Li and H. Shen and M. Shi and J. Feng and L. Pan and Jin-Hai Tang},
  year={2010}
}
  • Chengyun Yao, Xin-en Huang, +5 authors Jin-Hai Tang
  • Published 2010
  • Lung cancer is a leading cause of cancer-related death around the world. In China, the incidence of lung cancer is higher than any other cancers in men and is the second highest, after breast cancer, in women (Yang et al., 2005). The mortality rate of lung cancer is estimated to be 41.8 every one hundred thousand in men and 19.3 in women (Yang et al., 2004). Of all lung cancers, the non small cell lung cancers (NSCLCs) account for the majority, and close to 70% of the affected patients present… CONTINUE READING

    Figures and Tables from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES
    Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
    • 3,421
    • Highly Influential
    • PDF
    Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.
    • 93
    • Highly Influential
    An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.
    • 170
    • Highly Influential
    • PDF
    Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
    • 503
    • PDF